Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation [The Journal of Experimental Medicine, 210, 5, May (2013), (951-968)]doi 10.1084/jem.20120950;In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

Journal of Experimental Medicine

Volumn 210, Issue 5, 2013, Pages 951-968

  Pichiorri, Flavia ^a,d   Palmieri, Dario ^c,d   De Luca, Luciana ^e   Consiglio, Jessica ^a,d   You, Jia ^c,d   Rocci, Alberto ^c,d,f   Talabere, Tiffany ^a,d   Piovan, Claudia ^c,d,g   Lagana, Alessandro ^c,d   Cascione, Luciano ^c,d,h   Guan, Jingwen ^c,d   Gasparini, Pierluigi ^c,d   Balatti, Veronica ^c,d   Nuovo, Gerard ^c,d,i   Coppola, Vincenzo ^c,d   Hofmeister, Craig C ^a   Marcucci, Guido ^a,d   Byrd, John C ^a,d   Volinia, Stefano ^c,d,j   Shapiro, Charles L ^b,d   Freitas, Michael A ^c,d   Croce, Carlo M ^c,d   more..

^a Division of Nuclear Medicine   (United States)

^b Department of Internal Medicine Division of Medical Oncology Starling Loving Hall   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e Istituto di Ricovero e Cura   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h UNIVERSITY OF CATANIA   (Italy)

ⁱ Phylogeny Inc   (United States)

^j UNIVERSITY OF FERRARA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; MICRORNA; MICRORNA 103; MICRORNA 21; MICRORNA 221; MICRORNA 222; NUCLEOLIN; UNCLASSIFIED DRUG; AGRO 100; DRUG DERIVATIVE; ESTRADIOL; FULVESTRANT; GUANINE; OLIGODEOXYRIBONUCLEOTIDE; PHOSPHOPROTEIN; RNA BINDING PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER AGGRESSIVENESS; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; UPREGULATION; ANIMAL; BREAST TUMOR; CELL PROLIFERATION; CELL STRAIN HEK293; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR GENE; TUMOR INVASION;

ANIMALS; APTAMERS, NUCLEOTIDE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GENES, NEOPLASM; GUANINE; HEK293 CELLS; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC; UP-REGULATION;

MLCS; MLOWN;

EID: 84879585408     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.2012095001172017c     Document Type: Erratum

References (70)

1. Abdelmohsen, K., K. Tominaga, E.K. Lee, S. Srikantan, M.J. Kang, M.M. Kim, R. Selimyan, J.L. Martindale, X. Yang, F. Carrier, et al. 2011. Enhanced translation by Nucleolin via G-rich elements in coding and non-coding regions of target mRNAs. Nucleic Acids Res. 39:8513-8530. http://dx.doi.org/10.1093/nar/gkr488
2. Akar, U., B. Ozpolat, K. Mehta, G. Lopez-Berestein, D. Zhang, N.T. Ueno, G.N. Hortobagyi, and B. Arun. 2010. Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model. Mol. Cancer Ther. 9:1180-1187. http://dx.doi.org/10.1158/1535-7163.MCT-09-1025
3. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5
4. Bates, P.J., E.W. Choi, and L.V. Nayak. 2009a. G-rich oligonucleotides for cancer treatment. Methods Mol. Biol. 542:379-392. http://dx.doi.org/10.1007/978-1-59745-561-9_21
5. Bates, P.J., D.A. Laber, D.M. Miller, S.D. Thomas, and J.O. Trent. 2009b. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp. Mol. Pathol. 86:151-164. http://dx.doi.org/10.1016/j.yexmp.2009.01.004
6. Brooks, T.A., and L.H. Hurley. 2010. Targeting MYC Expression through G-Quadruplexes. Genes Cancer. 1:641-649. http://dx.doi.org/10.1177/1947601910377493
7. Calin, G.A., M. Ferracin, A. Cimmino, G. Di Leva, M. Shimizu, S.E. Wojcik, M.V. Iorio, R. Visone, N.I. Sever, M. Fabbri, et al. 2005. A MicroRNA signature associated with prognosis and progression inchronic lymphocytic leukemia. N. Engl. J. Med. 353:1793-1801. http://dx.doi.org/10.1056/NEJMoa050995
8. Campagna, D., A. Albiero, A. Bilardi, E. Caniato, C. Forcato, S. Manavski, N. Vitulo, and G. Valle. 2009. PASS: a program to align short sequences. Bioinformatics. 25:967-968. http://dx.doi.org/10.1093/bioinformatics/btp087
9. Chang, S., R.H. Wang, K. Akagi, K.A. Kim, B.K. Martin, L. Cavallone, D.C. Haines, M. Basik, P. Mai, E. Poggi, et al; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). 2011. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat. Med. 17:1275-1282. http://dx.doi.org/10.1038/nm.2459
10. Croce, C.M. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10:704-714. http://dx.doi.org/10.1038/nrg2634
11. Darido, C., S.R. Georgy, T. Wilanowski, S. Dworkin, A. Auden, Q. Zhao, G. Rank, S. Srivastava, M.J. Finlay, A.T. Papenfuss, et al. 2011. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell. 20:635-648. http://dx.doi.org/10.1016/j.ccr.2011.10.014
12. Destouches, D., N. Page, Y. Hamma-Kourbali, V. Machi, O. Chaloin, S. Frechault, C. Birmpas, P. Katsoris, J. Beyrath, P. Albanese, et al. 2011. A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins. Cancer Res. 71:3296-3305. http://dx.doi.org/10.1158/0008-5472.CAN-10-3459
13. Di Leva, G., P. Gasparini, C. Piovan, A. Ngankeu, M. Garofalo, C. Taccioli, M.V. Iorio, M. Li, S. Volinia, H. Alder, et al. 2010. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J. Natl. Cancer Inst. 102:706-721. http://dx.doi.org/10.1093/jnci/djq102
14. El Khoury, D., D. Destouches, R. Lengagne, B. Krust, Y. Hamma-Kourbali, M. Garcette, S. Niro, M. Kato, J.P. Briand, J. Courty, et al. 2010. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. BMC Cancer. 10:325. http://dx.doi.org/10.1186/1471-2407-10-325
15. Esteva, F.J., H. Guo, S.Y. Zhang, C. Santa-Maria, S. Stone, J.S. Lanchbury, A.A. Sahin, G.N. Hortobagyi, and D.H. Yu. 2010. PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer. Am. J. Pathol. 177:1647-1656. http://dx.doi.org/10.2353/ajpath.2010.090885
16. Farazi, T.A., H.M. Horlings, J.J. Ten Hoeve, A. Mihailovic, H. Halfwerk, P. Morozov, M. Brown, M. Hafner, F. Reyal, M. van Kouwenhove, et al. 2011. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 71:4443-4453. http://dx.doi.org/10.1158/0008-5472.CAN-11-0608
17. Farin, K., A. Di Segni, A. Mor, and R. Pinkas-Kramarski. 2009. Structurefunction analysis of nucleolin and ErbB receptors interactions. PLoS ONE. 4:e6128. http://dx.doi.org/10.1371/journal.pone.0006128
18. Farin, K., S. Schokoroy, R. Haklai, I. Cohen-Or, G. Elad-Sfadia, M.E. Reyes-Reyes, P.J. Bates, A.D. Cox, Y. Kloog, and R. Pinkas-Kramarski. 2011. Oncogenic synergism between ErbB1, nucleolin, and mutant Ras. Cancer Res. 71:2140-2151. http://dx.doi.org/10.1158/0008-5472.CAN-10-2887
19. Fortina, P., and S. Surrey. 2008. Digital mRNA profiling. Nat. Biotechnol. 26:293-294. http://dx.doi.org/10.1038/nbt0308-293
20. Frankel, L.B., N.R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A.H. Lund. 2008. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283:1026-1033. http://dx.doi.org/10.1074/jbc. M707224200
21. Fukuda, T., K. Yamagata, S. Fujiyama, T. Matsumoto, I. Koshida, K. Yoshimura, M. Mihara, M. Naitou, H. Endoh, T. Nakamura, et al. 2007. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat. Cell Biol. 9:604-611. http://dx.doi.org/10.1038/ncb1577
22. Garofalo, M., and C.M. Croce. 2011. microRNAs: Master regulators as potential therapeutics in cancer. Annu. Rev. Pharmacol. Toxicol. 51:25-43. http://dx.doi.org/10.1146/annurev-pharmtox-010510-100517
23. Garofalo, M., C. Quintavalle, G. Di Leva, C. Zanca, G. Romano, C. Taccioli, C.G. Liu, C.M. Croce, and G. Condorelli. 2008. MicroRNAsignatures of TRAIL resistance in human non-small cell lung cancer. Oncogene. 27:3845-3855. http://dx.doi.org/10.1038/onc.2008.6
24. Garofalo, M., G. Di Leva, G. Romano, G. Nuovo, S.S. Suh, A. Ngankeu, C. Taccioli, F. Pichiorri, H. Alder, P. Secchiero, et al. 2009. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell. 16:498-509. http://dx.doi.org/10.1016/j.ccr.2009.10.014
25. Ginisty, H., F. Amalric, and P. Bouvet. 1998. Nucleolin functions in the first step of ribosomal RNA processing. EMBO J. 17:1476-1486. http://dx.doi.org/10.1093/emboj/17.5.1476
26. Greco, A., L. Arata, E. Soler, X. Gaume, Y. Couté, S. Hacot, A. Callé, K. Monier, A.L. Epstein, J.C. Sanchez, et al. 2012. Nucleolin interacts with US11 protein of herpes simplex virus 1 and is involved in its trafficking. J. Virol. 86:1449-1457. http://dx.doi.org/10.1128/JVI.06194-11
27. Hovanessian, A.G., C. Soundaramourty, D. El Khoury, I. Nondier, J. Svab, and B. Krust. 2010. Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization. PLoS ONE. 5:e15787. http://dx.doi.org/10.1371/journal.pone.0015787
28. Huber, W., A. von Heydebreck, H. Sültmann, A. Poustka, and M. Vingron. 2002. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 18:S96-S104. http://dx.doi.org/10.1093/bioinformatics/18.suppl_1.S96
29. Hwang, H.W., E.A. Wentzel, and J.T. Mendell. 2009. Cell-cell contact globally activates microRNA biogenesis. Proc. Natl. Acad. Sci. USA. 106:7016-7021. http://dx.doi.org/10.1073/pnas.0811523106
30. Iliopoulos, D., S.A. Jaeger, H.A. Hirsch, M.L. Bulyk, and K. Struhl. 2010. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell. 39:493-506. http://dx.doi.org/10.1016/j.molcel.2010.07.023
31. Inui, M., G. Martello, and S. Piccolo. 2010. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11:264-275. http://dx.doi.org/10.1038/nrm2868
32. Ioffe, Y.J., K.B. Chiappinelli, D.G. Mutch, I. Zighelboim, and P.J. Goodfellow. 2012. Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis? Gynecol. Oncol. 124:340-346. http://dx.doi.org/10.1016/j.ygyno.2011.10.011
33. Ireson, C.R., and L.R. Kelland. 2006. Discovery and development of anticancer aptamers. Mol. Cancer Ther. 5:2957-2962. http://dx.doi.org/10.1158/1535-7163.MCT-06-0172
34. Ishimaru, D., L. Zuraw, S. Ramalingam, T.K. Sengupta, S. Bandyopadhyay, A. Reuben, D.J. Fernandes, and E.K. Spicer. 2010. Mechanism of regulation of bcl-2 mRNA by nucleolin and A+U-rich element-binding factor 1 (AUF1). J. Biol. Chem. 285:27182-27191. http://dx.doi.org/10.1074/jbc. M109.098830
35. Jalal, C., H. Uhlmann-Schiffler, and H. Stahl. 2007. Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation. Nucleic Acids Res. 35:3590-3601. http://dx.doi.org/10.1093/nar/gkm058
36. Keefe, A.D., S. Pai, and A. Ellington. 2010. Aptamers as therapeutics. Nat. Rev. Drug Discov. 9:537-550. http://dx.doi.org/10.1038/nrd3141
37. Krust, B., D. El Khoury, C. Soundaramourty, I. Nondier, and A.G. Hovanessian. 2011. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin. Biochimie. 93:426-433. http://dx.doi.org/10.1016/j.biochi.2010.10.015
38. Laganà, A., S. Forte, A. Giudice, M.R. Arena, P.L. Puglisi, R. Giugno, A. Pulvirenti, D. Shasha, and A. Ferro. 2009. miRò: a miRNA knowledge base. Database (Oxford). 2009:bap008. http://dx.doi.org/10.1093/database/bap008
39. Martello, G., A. Rosato, F. Ferrari, A. Manfrin, M. Cordenonsi, S. Dupont, E. Enzo, V. Guzzardo, M. Rondina, T. Spruce, et al. 2010. A MicroRNA targeting dicer for metastasis control. Cell. 141:1195-1207. http://dx.doi.org/10.1016/j.cell.2010.05.017
40. Mercatelli, N., V. Coppola, D. Bonci, F. Miele, A. Costantini, M. Guadagnoli, E. Bonanno, G. Muto, G.V. Frajese, R. De Maria, et al. 2008. The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS ONE. 3:e4029. http://dx.doi.org/10.1371/journal.pone.0004029
41. Mortazavi, A., B.A. Williams, K. McCue, L. Schaeffer, and B. Wold. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods. 5:621-628. http://dx.doi.org/10.1038/nmeth.1226
42. Nuovo, G., E.J. Lee, S. Lawler, J. Godlewski, and T. Schmittgen. 2009. In situ detection of mature microRNAs by labeled extension on ultramer templates. Biotechniques. 46:115-126. http://dx.doi.org/10.2144/000113068
43. Otake, Y., S. Soundararajan, T.K. Sengupta, E.A. Kio, J.C. Smith, M. Pineda-Roman, R.K. Stuart, E.K. Spicer, and D.J. Fernandes. 2007. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood. 109:3069-3075.
44. Pichiorri, F., S.S. Suh, A. Rocci, L. De Luca, C. Taccioli, R. Santhanam, W. Zhou, D.M. Benson Jr., C. Hofmainster, H. Alder, et al. 2010. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell. 18:367-381. http://dx.doi.org/10.1016/j.ccr.2010.09.005
45. Pickering, B.F., D. Yu, and M.W. Van Dyke. 2011. Nucleolin protein interacts with the microprocessor complex to affect biogenesis of microRNAs 15a and 16. J. Biol. Chem. 286:44095-44103. http://dx.doi.org/10.1074/jbc. M111.265439
46. Pillai, R.S., S.N. Bhattacharyya, and W. Filipowicz. 2007. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 17:118-126. http://dx.doi.org/10.1016/j.tcb.2006.12.007
47. Polyak, K., and R.A. Weinberg. 2009. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer. 9:265-273. http://dx.doi.org/10.1038/nrc2620
48. Rao, X., G. Di Leva, M. Li, F. Fang, C. Devlin, C. Hartman-Frey, M.E. Burow, M. Ivan, C.M. Croce, and K.P. Nephew. 2011. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene. 30:1082-1097. http://dx.doi.org/10.1038/onc.2010.487
49. Reyes-Reyes, E.M., and S.K. Akiyama. 2008. Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells. Exp. Cell Res. 314:2212-2223. http://dx.doi.org/10.1016/j.yexcr.2008.03.016
50. Rissland, O.S., S.J. Hong, and D.P. Bartel. 2011. MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes. Mol. Cell. 43:993-1004. http://dx.doi.org/10.1016/j.molcel.2011.08.021
51. Sayed, D., M. He, C. Hong, S. Gao, S. Rane, Z. Yang, and M. Abdellatif. 2010. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J. Biol. Chem. 285:20281-20290. http://dx.doi.org/10.1074/jbc. M110.109207
52. Shi, H., Y. Huang, H. Zhou, X. Song, S. Yuan, Y. Fu, and Y. Luo. 2007. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood. 110:2899-2906. http://dx.doi.org/10.1182/blood-2007-01-064428
53. Shiohama, A., T. Sasaki, S. Noda, S. Minoshima, and N. Shimizu. 2007. Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. Exp. Cell Res. 313:4196-4207. http://dx.doi.org/10.1016/j.yexcr.2007.07.020
54. Shorning, B.Y., D. Griffiths, and A.R. Clarke. 2011. Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder. PLoS ONE. 6:e16209. http://dx.doi.org/10.1371/journal.pone.0016209
55. Simon, R., M.D. Radmacher, K. Dobbin, and L.M. McShane. 2003. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J. Natl. Cancer Inst. 95:14-18. http://dx.doi.org/10.1093/jnci/95.1.14
56. Soundararajan, S., W. Chen, E.K. Spicer, N. Courtenay-Luck, and D.J. Fernandes. 2008. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res. 68:2358-2365. http://dx.doi.org/10.1158/0008-5472.CAN-07-5723
57. Srivastava, M., and H.B. Pollard. 1999. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 13:1911-1922.
58. Sun, D., K. Guo, and Y.J. Shin. 2011. Evidence of the formation of Gquadruplex structures in the promoter region of the human vascular endothelial growth factor gene. Nucleic Acids Res. 39:1256-1265. http://dx.doi.org/10.1093/nar/gkq926
59. Tayyari, F., D. Marchant, T.J. Moraes, W. Duan, P. Mastrangelo, and R.G. Hegele. 2011. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 17:1132-1135. http://dx.doi.org/10.1038/nm.2444
60. Teng, Y., A.C. Girvan, L.K. Casson, W.M. Pierce Jr., M. Qian, S.D. Thomas, and P.J. Bates. 2007. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin. Cancer Res. 67:10491-10500. http://dx.doi.org/10.1158/0008-5472.CAN-06-4206
61. Ventura, A., and T. Jacks. 2009. MicroRNAs and cancer: short RNAs go a long way. Cell. 136:586-591. http://dx.doi.org/10.1016/j.cell.2009.02.005
62. Visone, R., A. Veronese, L.Z. Rassenti, V. Balatti, D.K. Pearl, M. Acunzo, S. Volinia, C. Taccioli, T.J. Kipps, and C.M. Croce. 2011. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood. 118:3072-3079. http://dx.doi.org/10.1182/blood-2011-01-333484
63. Volinia, S., G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA. 103:2257-2261. http://dx.doi.org/10.1073/pnas.0510565103
64. Volinia, S., M. Galasso, S. Costinean, L. Tagliavini, G. Gamberoni, A. Drusco, J. Marchesini, N. Mascellani, M.E. Sana, R. Abu Jarour, et al. 2010. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 20:589-599. http://dx.doi.org/10.1101/gr.098046.109
65. Watanabe, T., H. Tsuge, T. Imagawa, D. Kise, K. Hirano, M. Beppu, A. Takahashi, K. Yamaguchi, H. Fujiki, and M. Suganuma. 2010. Nucleolin as cell surface receptor for tumor necrosis factor-alpha inducing protein: a carcinogenic factor of Helicobacter pylori. J. Cancer Res. Clin. Oncol. 136: 911-921. http://dx.doi.org/10.1007/s00432-009-0733-y
66. Will, S., K. Reiche, I.L. Hofacker, P.F. Stadler, and R. Backofen. 2007. Inferring noncoding RNA families and classes by means of genome-scale structure-based clustering. PLOS Comput. Biol. 3:e65. http://dx.doi.org/10.1371/journal.pcbi.0030065
67. Wu, C.D., H.W. Chou, Y.S. Kuo, R.M. Lu, Y.C. Hwang, H.C. Wu, and C.T. Lin. 2012. Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy. Oncol. Rep. 27:94-100.
68. Wu, H., H. Xu, L.J. Miraglia, and S.T. Crooke. 2000. Human RNase III is a 160-kDa protein involved in preribosomal RNA processing. J. Biol. Chem. 275:36957-36965. http://dx.doi.org/10.1074/jbc. M005494200
69. Yeung, K.Y., M. Medvedovic, and R.E. Bumgarner. 2003. Clustering gene-expression data with repeated measurements. Genome Biol. 4:R34. http://dx.doi.org/10.1186/gb-2003-4-5-r34
70. Zhang, B.G., J.F. Li, B.Q. Yu, Z.G. Zhu, B.Y. Liu, and M. Yan. 2012. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol. Rep. 27:1019-1026.